Select your country

Websites worldwide

Select a country to go to the website of the respective STADA sales company.

Belgium (1)

Bosnia-Herzegovina (1)

Croatia (1)

Denmark (1)

Hungary (1)

Italy (1)

Montenegro (1)

Romania (1)

Russia (1)

Serbia (1)

Slovenia (1)

Switzerland (1)

Ukraine (1)

21.07.2021
Calliditas Therapeutics and STADA
Calliditas Therapeutics and STADA

Calliditas Therapeutics and STADA partner to register and commercialize specialty therapy for IgA Nephropathy in Europe

Read more

12.07.2021
Enzymatica and STADA extend agreement on ViruProtect to Vietnam
Enzymatica and STADA extend agreement on ViruProtect to Vietnam

Enzymatica has licensed to STADA exclusive rights to market and sell ViruProtect® (distributed by Enzymatica as ColdZyme®) in Vietnam.

Read more

17.06.2021
STADA Health Report 2021
STADA Health Report 2021

A year that changed Europe’s health landscape

Read more

08.03.2021
Frankfurter Allgemeine Zeitung
Frankfurter Allgemeine Zeitung

STADA wants to set the gold standard

Read more

05.03.2021
STADA attracts Bryan Kim as Global Head of Specialties
STADA attracts Bryan Kim as Global Head of Specialties

Experienced life sciences executive Bryan Kim will join STADA from 1st April 2021.

Read more

15.02.2021
STADA launches novel Parkinson’s therapy in Germany and Austria
STADA launches novel Parkinson’s therapy in Germany and Austria

In October, STADA acquired the rights to a triple combination product with the active ingredients levodopa, carbidopa and entacapone.

Read more